Preloader Close
  • Digital therapy and innovative rehabilitation (Mobile technology, psychoeducation, self-help, information, and communication technologies)
  • Lifestyle, exercise, nutrition, nutraceuticals (Omega-3), CBD, complementary therapies
  • Artificial intelligence / machine learning
  • Big data / mega-analysis projects
  • Big consortia - longitudinal projects
  • Developmental affective psychopathology (Mood/anxiety disorders in children/adolescents)
  • Perinatal affective psychopathology
  • Microbiome (Gut and microbiome in mood & anxiety disorders)
  • Innovative psychopharmacology
  • Psychedelics and rapid acting therapies, ketamine
  • Treatment post Covid; Virtual clinics and assessments
  • Brain stimulation and physical treatments: rTMS, VNS, DBS, ECT
  • Psychiatric/medical/addiction comorbidity in mood & anxiety disorders
  • Autoimmune disorders - (neuro-)inflammation in mood & anxiety disorder
  • Integration of biological and psychological treatments in mood & anxiety disorders
  • Cultural and gender variations in mood & anxiety disorders
  • Genetic and pharmacogenetic approaches to mood & anxiety disorders
  • Epigenetics, prenatal exposure to stress and mood & anxiety disorders
  • Brain structure and function in mood & anxiety disorders
  • Service development for mood & anxiety disorders
  • Pre-onset identification of mood & anxiety disorders
  • Measurement challenges; innovative research designs in mood & anxiety disorders
  • Mood and anxiety disorders in the elderly
  • Biomarkers for mood & anxiety disorders
  • Suicide in mood & anxiety disorders
  • Sleep-wake cycle/circadian rhythm disturbances in mood & anxiety disorders
  • Patient representation/self-management